Antwerp, Belgium

Jessie Theuns

This inventor holds 1 USPTO granted patent. Top assignees: University of Antwerp, Vib Vzw. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jessie Theuns. Retrieved from https://idiyas.com/inventor/jessie-theuns

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jessie Theuns in Alzheimer's Disease Research.

Introduction

Jessie Theuns is an accomplished inventor based in Antwerp, Belgium. He has made significant contributions to the field of Alzheimer's disease research through his innovative work on genetic mutations. His research focuses on the amyloid precursor protein (APP) and its implications for Alzheimer's disease diagnosis and treatment.

Latest Patents

Jessie Theuns holds a patent for "Promoter mutations that increase amyloid precursor protein expression." This invention relates to specific mutations in the APP promoter region that lead to a significant increase in APP expression. The increase in APP expression is closely associated with Alzheimer's disease, making these mutations valuable for diagnosis and the development of transgenic animal models for studying the disease.

Career Highlights

Throughout his career, Jessie Theuns has worked with notable institutions, including the University of Antwerp and VIB (Flanders Institute for Biotechnology). His research has been pivotal in advancing the understanding of genetic factors contributing to Alzheimer's disease.

Collaborations

Jessie has collaborated with Christine Van Broeckhoven, a prominent figure in Alzheimer's research. Their partnership has fostered advancements in the study of genetic mutations related to the disease.

Conclusion

Jessie Theuns is a key inventor in the field of Alzheimer's disease research, with a focus on genetic mutations that enhance our understanding of the condition. His work continues to pave the way for future innovations in diagnosis and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…